Cargando…

Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models

Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disorder that mostly affects the synovial joints and can promote both cartilage and bone tissue destruction. Several conservative treatments are available to relieve pain and control the inflammation; however, traditional drugs admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Isabel Maria, Fernandes, Diogo Castro, Cengiz, Ibrahim Fatih, Reis, Rui Luís, Oliveira, Joaquim Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219548/
https://www.ncbi.nlm.nih.gov/pubmed/34156535
http://dx.doi.org/10.1007/s10856-021-06547-1
_version_ 1783710953634791424
author Oliveira, Isabel Maria
Fernandes, Diogo Castro
Cengiz, Ibrahim Fatih
Reis, Rui Luís
Oliveira, Joaquim Miguel
author_facet Oliveira, Isabel Maria
Fernandes, Diogo Castro
Cengiz, Ibrahim Fatih
Reis, Rui Luís
Oliveira, Joaquim Miguel
author_sort Oliveira, Isabel Maria
collection PubMed
description Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disorder that mostly affects the synovial joints and can promote both cartilage and bone tissue destruction. Several conservative treatments are available to relieve pain and control the inflammation; however, traditional drugs administration are not fully effective and present severe undesired side effects. Hydrogels are a very attractive platform as a drug delivery system to guarantee these handicaps are reduced, and the therapeutic effect from the drugs is maximized. Furthermore, hydrogels can mimic the physiological microenvironment and have the mechanical behavior needed for use as cartilage in vitro model. The testing of these advanced delivery systems is still bound to animal disease models that have shown low predictability. Alternatively, hydrogel-based human dynamic in vitro systems can be used to model diseases, bypassing some of the animal testing problems. RA dynamic disease models are still in an embryonary stage since advances regarding healthy and inflamed cartilage models are currently giving the first steps regarding complexity increase. Herein, recent studies using hydrogels in the treatment of RA, featuring different hydrogel formulations are discussed. Besides, their use as artificial extracellular matrices in dynamic in vitro articular cartilage is also reviewed. [Image: see text]
format Online
Article
Text
id pubmed-8219548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82195482021-07-09 Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models Oliveira, Isabel Maria Fernandes, Diogo Castro Cengiz, Ibrahim Fatih Reis, Rui Luís Oliveira, Joaquim Miguel J Mater Sci Mater Med Delivery Systems Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disorder that mostly affects the synovial joints and can promote both cartilage and bone tissue destruction. Several conservative treatments are available to relieve pain and control the inflammation; however, traditional drugs administration are not fully effective and present severe undesired side effects. Hydrogels are a very attractive platform as a drug delivery system to guarantee these handicaps are reduced, and the therapeutic effect from the drugs is maximized. Furthermore, hydrogels can mimic the physiological microenvironment and have the mechanical behavior needed for use as cartilage in vitro model. The testing of these advanced delivery systems is still bound to animal disease models that have shown low predictability. Alternatively, hydrogel-based human dynamic in vitro systems can be used to model diseases, bypassing some of the animal testing problems. RA dynamic disease models are still in an embryonary stage since advances regarding healthy and inflamed cartilage models are currently giving the first steps regarding complexity increase. Herein, recent studies using hydrogels in the treatment of RA, featuring different hydrogel formulations are discussed. Besides, their use as artificial extracellular matrices in dynamic in vitro articular cartilage is also reviewed. [Image: see text] Springer US 2021-06-22 2021 /pmc/articles/PMC8219548/ /pubmed/34156535 http://dx.doi.org/10.1007/s10856-021-06547-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Delivery Systems
Oliveira, Isabel Maria
Fernandes, Diogo Castro
Cengiz, Ibrahim Fatih
Reis, Rui Luís
Oliveira, Joaquim Miguel
Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
title Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
title_full Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
title_fullStr Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
title_full_unstemmed Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
title_short Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
title_sort hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
topic Delivery Systems
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219548/
https://www.ncbi.nlm.nih.gov/pubmed/34156535
http://dx.doi.org/10.1007/s10856-021-06547-1
work_keys_str_mv AT oliveiraisabelmaria hydrogelsinthetreatmentofrheumatoidarthritisdrugdeliverysystemsandartificialmatricesfordynamicinvitromodels
AT fernandesdiogocastro hydrogelsinthetreatmentofrheumatoidarthritisdrugdeliverysystemsandartificialmatricesfordynamicinvitromodels
AT cengizibrahimfatih hydrogelsinthetreatmentofrheumatoidarthritisdrugdeliverysystemsandartificialmatricesfordynamicinvitromodels
AT reisruiluis hydrogelsinthetreatmentofrheumatoidarthritisdrugdeliverysystemsandartificialmatricesfordynamicinvitromodels
AT oliveirajoaquimmiguel hydrogelsinthetreatmentofrheumatoidarthritisdrugdeliverysystemsandartificialmatricesfordynamicinvitromodels